Powerflox 50 mg/ml Solution for Injection for Cattle, Pigs, Dogs and Cats

Χώρα: Ηνωμένο Βασίλειο

Γλώσσα: Αγγλικά

Πηγή: VMD (Veterinary Medicines Directorate)

Δραστική ουσία:

Enrofloxacin

Διαθέσιμο από:

Virbac

Φαρμακολογική κατηγορία (ATC):

QJ01MA90

INN (Διεθνής Όνομα):

Enrofloxacin

Φαρμακοτεχνική μορφή:

Solution for injection

Τρόπος διάθεσης:

POM-V - Prescription Only Medicine – Veterinarian

Θεραπευτική ομάδα:

Cats, Cattle, Dogs, Pigs

Θεραπευτική περιοχή:

Antimicrobial

Καθεστώς αδειοδότησης:

Expired

Ημερομηνία της άδειας:

2009-07-22

Αρχείο Π.Χ.Π.

Revised: November 2014
AN: 00887/2014
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Powerflox 50 mg/ml solution for injection for cattle, pigs, dogs and
cats
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml of solution for injection contains:
ACTIVE SUBSTANCE:
Enrofloxacin
50 mg
EXCIPIENT(S):
n-butyl alcohol as antimicrobial preservative
30 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection
Clear yellow solution practically free from particles.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle (calves), pigs, dogs and cats.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
CALVES:
Treatment of infections of the respiratory tract caused by
enrofloxacin
susceptible strains of _Pasteurella multocida, Mannheimia haemolytica_
and
_Mycoplasma_ spp.
Treatment of infections of the alimentary tract caused by enrofloxacin
susceptible strains of _Escherichia coli_.
Treatment of septicaemia caused by enrofloxacin susceptible strains of
_Escherichia coli_.
Treatment of acute mycoplasma-associated arthritis due to enrofloxacin
susceptible strains of _Mycoplasma bovis_.
PIGS:
Treatment of infections of the respiratory tract caused by
enrofloxacin
susceptible strains of _Pasteurella multocida, Mycoplasma_ spp. and
_Actinobacillus pleuropneumoniae_.
Treatment of infections of the alimentary tract caused by enrofloxacin
susceptible strains of _Escherichia coli_.
Treatment of septicaemia caused by enrofloxacin susceptible strains of
_Escherichia coli._
Revised: November 2014
AN: 00887/2014
Page 2 of 7
DOGS:
Treatment of infections of the alimentary, respiratory and urogenital
tracts
(including prostatitis, adjunctive antibiotic therapy for pyometra),
skin and
wound infections, otitis (externa/media) caused by enrofloxacin
susceptible
strains of _Staphylococcus_ spp., _Escherichia coli_, _Pasteurella_
spp., _Klebsiella_
spp., _Bordetella_ spp., _Pseudomonas_ spp. and _Proteus_ spp.
CATS:
Treatment of infections of the alimentary, respir